Mount Sinai Health System is an integrated health system based in New York City, offering distinguished care through seven hospital campuses, a medical school, and extensive ambulatory services. The organization prioritizes patient-centric innovation, collaboration, and biomedical education, attracting 48,000 employees dedicated to advancing medicine globally.
This postdoctoral fellowship at Mount Sinai Health System involves participating in research related to myeloid malignancies, specifically induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). The role includes experiments involving culture, genetic modification, transplantation in mice, molecular analyses, and data analysis. The candidate will also participate in research into COVID-19 to generate iPSCs from patients. The fellowship provides a platform to advance knowledge and innovation within a leading healthcare system.
Mount Sinai Health System is an integrated health system based in New York City, offering distinguished care through seven hospital campuses, a medical school, and extensive ambulatory services. The organization prioritizes patient-centric innovation, collaboration, and biomedical education, attracting 48,000 employees dedicated to advancing medicine globally.